Kelly Kennewick

Kelly is a senior graduate student and a Gilliam/HHMI scholar. She grew up in Seattle and later attended University of Washington where she received her BS in Biochemistry. She then moved down to Los Angeles and began working as a research associate in the Forman Lab at City of Hope. There, she developed and optimized CAR T cells for the treatment of bone metastatic prostate cancer. After four years at City of Hope, she began graduate school at UCLA. She now works in the lab of Dr. Steven Bensinger exploring questions regarding the crosstalk between lipid metabolism and T cell immunity. Her current projects include applying advanced mass spectrometry–based analytic approaches to explore the relationship between lipid composition and T cell function in healthy and disease states.